Sage Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $36M | 1.7M | 21.67 |
| 2023-09-30 | $34M | 1.7M | 20.58 |
| 2023-06-30 | $80M | 1.7M | 47.02 |
| 2023-03-31 | $54M | 1.3M | 41.10 |
| 2022-12-31 | $53M | 1.4M | 37.38 |
| 2022-06-30 | $51M | 1.6M | 32.68 |
| 2022-03-31 | $53M | 1.6M | 32.68 |
| 2021-12-31 | $69M | 1.6M | 43.92 |
| 2021-03-31 | $85M | 1.1M | 74.84 |
| 2020-12-31 | $130M | 1.5M | 86.51 |
| 2020-09-30 | $92M | 1.5M | 59.62 |
| 2020-06-30 | $58M | 1.4M | 41.58 |
| 2020-03-31 | $0 | 1.4M | 0.00 |
| 2019-12-31 | $100M | 1.4M | 71.86 |
| 2019-09-30 | $129M | 922k | 139.75 |
| 2019-06-30 | $164M | 914k | 179.58 |
| 2019-03-31 | $151M | 952k | 158.56 |
| 2018-12-31 | $91M | 952k | 95.79 |
| 2018-09-30 | $132M | 936k | 141.25 |
| 2018-06-30 | $146M | 933k | 156.53 |
| 2018-03-31 | $111M | 722k | 153.85 |
| 2017-12-31 | $130M | 787k | 164.71 |
| 2017-06-30 | $65M | 819k | 79.64 |
| 2017-03-31 | $59M | 834k | 71.08 |
| 2016-12-31 | $51M | 999k | 51.07 |
| 2016-09-30 | $56M | 1.2M | 46.05 |
| 2016-06-30 | $32M | 1.1M | 30.13 |
| 2016-03-31 | $33M | 1.0M | 32.06 |
| 2015-12-31 | $56M | 966k | 58.29 |
| 2015-09-30 | $38M | 900k | 42.32 |
| 2015-06-30 | $59M | 810k | 72.98 |
| 2015-03-31 | $40M | 795k | 50.23 |
| 2014-12-31 | $6.5M | 178k | 36.67 |
| 2014-09-30 | $1.8M | 59k | 31.36 |